Abstract
OBJECTIVE: Acinetobacter baumannii is one of the most drug-resistant microorganisms in hospital-acquired infections. The treatment of choice for A. baumannii infections is carbapenems (e.g., meropenem). However, A. baumannii can develop resistance to all clinical antibiotics associated with the formation of persister cells. We first assessed the virulence and differential expression levels of outer membrane protein W (OmpW) in A. baumannii persister cells and A. baumannii regular cells in vivo and in vitro after exposure to meropenem. METHODS: Persister cells were confirmed using a standard method. OmpW characterization was performed using western blot analysis, and OmpW expression was detected using real-time polymerase chain reaction (PCR) after ribonucleic acid (RNA) extraction. An A. baumannii virulence assay was performed using the Galleria mellonella larvae model. Relative expression was calculated using the 2(-ΔΔCT) method. RESULTS: The presence of bona fide A. baumannii persister cells was confirmed after 48 h of meropenem exposure at 15 μg/mL, with levels reaching 0.3216% of the initial bacterial population and a survival fraction of 0.081%. OmpW genes were highly expressed at more than 2.68-fold (p = 0.01) with meropenem exposure at 1 μg/mL and 8.61-fold (p = 0.0005) with meropenem exposure at 15 μg/mL. There was a significant difference in the lethal dose 50% (LD(50)) at 24 h postinfection between persister cells (2.01 × 10(5) CFU/larva) and regular cells (4.73 × 10(5) CFU/larva) at p < 0.05. Similarly, there was a significant difference between the LD(50) at 48 h for persister cells (1.61 × 10(5) CFU/larva) and regular cells (4.08 × 10(5) CFU/larva) at p < 0.05. However, there was no statistically significant difference in the LD(50) at 72, 96, and 120 h postinfection. CONCLUSION: OmpW overexpression in meropenem-exposed A. baumannii persister cells enhances virulence and reveals a candidate target for preventing and controlling A. baumannii persister cells.